PE
HAE icon

Point72 Europe’s Haemonetics HAE Stock Holding History

Point72 Europe’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$167K Buy
+3,433
New +$212K 0.01% 213

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Point72 Europe's HAE Position: Q3 2025 in Review

Point72 Europe opened a new position in Haemonetics (HAE) in Q3 2025: 3,433 shares worth $167K. The stake represents 0.01% of the portfolio and ranks #213 among its holdings.

301 funds tracked by Wall St. Rank hold HAE as of Q3 2025.

  • Point72 Europe held 3,433 shares of Haemonetics worth $167K as of Q3 2025.
  • Haemonetics was a new Point72 Europe position in Q3 2025.
  • Haemonetics made up 0.01% of Point72 Europe's portfolio in Q3 2025, its #213 holding.
  • 301 funds tracked by Wall St. Rank held Haemonetics as of Q3 2025.

Based on Point72 Europe's 13F filing for Q3 2025, filed 14 Nov 2025.